DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ifex (Ifosfamide) - Current Clinical Trials

 
 



Ifex Related Clinical Trials

Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors [Active, not recruiting]

Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Recruiting]

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen [Active, not recruiting]

Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors [Completed]

Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors [Terminated]

Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery [Terminated]

Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors [Terminated]

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) [Completed]

A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma [Active, not recruiting]

A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus [Completed]

Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide [Completed]

Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma [Completed]

Bortezomib Plus ICE (BICE) Versus Standard ICE for Patients With Relapsed/Refractory Classical Hodgkin Lymphoma [Active, not recruiting]

Ph II Cabazitaxel/Ifosfamide DD Liposarcoma [Recruiting]

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy [Completed]

Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma [Recruiting]

Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma [Terminated]

Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors [Recruiting]

Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma [Completed]

A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer [Recruiting]

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma [Completed]

Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma [Recruiting]

A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer [Recruiting]

High-dose Chemotherapy for Poor-prognosis Relapsed Germ-Cell Tumors [Recruiting]

Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Terminated]

Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma [Recruiting]

Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin [Completed]

Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Recruiting]

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin [Completed]

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL [Recruiting]

Stem Cell Collection With Ofatumumab [Recruiting]

Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma [Recruiting]

S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Terminated]

Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer [Terminated]

A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall [Recruiting]

Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis [Completed]

TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients [Completed]

Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma [Completed]

Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma [Recruiting]

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Active, not recruiting]

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients [Completed]

Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide [Terminated]

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Completed]

Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors [Recruiting]

A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response [Terminated]

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies [Active, not recruiting]

A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma [Completed]

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors [Recruiting]

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma [Active, not recruiting]

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors [Active, not recruiting]

Phase I Study of Romidepsin Plus ICE for Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma [Recruiting]

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy [Terminated]

Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma [Completed]

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) [Active, not recruiting]

Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma [Recruiting]

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma [Recruiting]

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. [Completed]

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors [Recruiting]

Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors [Terminated]

Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Completed]

Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis [Recruiting]

Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells [Active, not recruiting]

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Completed]

Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus [Completed]

PET Scan Combined With CT Scan in Predicting Response in Patients Undergoing Chemotherapy and Surgery for Soft Tissue Sarcoma [Active, not recruiting]

Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma [Recruiting]

Rituximab and Combination Chemotherapy Followed By Thalidomide in Treating Patients With Previously Untreated Mantle Cell Lymphoma [Active, not recruiting]

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma [Recruiting]

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma [Completed]

Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia [Active, not recruiting]

MRI Sarcoma Non Invasive Thermometry [Completed]

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma [Terminated]

Study of Oral Palifosfamide Tris in Solid Tumors [Suspended]

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors [Completed]

Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Completed]

Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer [Recruiting]

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors [Suspended]

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma [Completed]

Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer [Completed]

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma [Active, not recruiting]

Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Completed]

Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma [Completed]

Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) [Recruiting]

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors [Active, not recruiting]

Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors [Recruiting]

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma [Active, not recruiting]

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide [Completed]

Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children [Completed]

Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma [Completed]

Pazopanib Hydrochloride Followed by Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017